Case Study: Merck KGaA, Darmstadt, Germany achieves faster, more collaborative biomarker analysis with JMP

Merck - Customer Case Study

Merck KGaA, Darmstadt, Germany, needed to speed biomarker research and make sense of increasingly complex oncology data to support personalized treatment development. To do that, the Merck team turned to JMP for exploratory analysis, enabling biostatisticians and subject matter experts to collaborate more effectively while investigating unexpected outcomes beyond the original clinical plan.

Using JMP’s interactive, user-friendly statistical tools, Merck scientists could visualize data, test models, and share findings more easily with internal stakeholders. The result was faster analysis, stronger statistical rigor and reproducibility, and measurable value in advancing oncology innovation; Merck also reported very positive feedback, with some subject matter experts wanting to use JMP themselves.

Merck

Angela Manginelli

Senior Scientist